SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-04-052724
Filing Date
2004-11-15
Accepted
2004-11-15 15:27:39
Documents
1
Period of Report
2004-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 7868
  Complete submission text file 0001209191-04-052724.txt   9771
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Issuer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address OSI PHARMACEUTICALS INC 58 S. SERVICE RD. MELVILLE NY 11747
VAN NOSTRAND ROBERT L (Reporting) CIK: 0001225198 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-15190 | Film No.: 041144775